|
C22ORF13 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.035400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.223000E-04 |
| Normal-vs-Stage2 |
8.931000E-01 |
| Normal-vs-Stage3 |
1.676160E-01 |
| Normal-vs-Stage4 |
3.811000E-01 |
| Stage1-vs-Stage2 |
3.439300E-03 |
| Stage1-vs-Stage3 |
4.903600E-02 |
| Stage1-vs-Stage4 |
2.677600E-02 |
| Stage2-vs-Stage3 |
2.287800E-01 |
| Stage2-vs-Stage4 |
3.962000E-01 |
| Stage3-vs-Stage4 |
7.018400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.819500E-03 |
| Normal-vs-AfricanAmerican |
6.832600E-01 |
| Normal-vs-Asian |
1.280790E-01 |
| Caucasian-vs-AfricanAmerican |
1.271970E-01 |
| Caucasian-vs-Asian |
4.676200E-01 |
| AfricanAmerican-vs-Asian |
9.954300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.513650E-01 |
| Normal-vs-Female |
7.59930000000519E-05 |
| Male-vs-Female |
5.177100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.719400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.158200E-03 |
| Normal-vs-Age(61-80Yrs) |
3.975900E-02 |
| Normal-vs-Age(81-100Yrs) |
2.081600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.381800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.620800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.888400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.208400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.340200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.015600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.152500E-04 |
| Normal-vs-Grade 2 |
1.499830E-03 |
| Normal-vs-Grade 3 |
6.389700E-02 |
| Normal-vs-Grade 4 |
3.966000E-01 |
| Grade 1-vs-Grade 2 |
1.134790E-01 |
| Grade 1-vs-Grade 3 |
4.155800E-02 |
| Grade 1-vs-Grade 4 |
6.280800E-03 |
| Grade 2-vs-Grade 3 |
1.416970E-01 |
| Grade 2-vs-Grade 4 |
1.043000E-01 |
| Grade 3-vs-Grade 4 |
5.780000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.80699999963174E-07 |
| Normal-vs-ccB subtype |
8.974800E-01 |
| ccA subtype-vs-ccB subtype |
7.17270000061276E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.686000E-02 |
| Normal-vs-N1 |
5.739200E-01 |
| N0-vs-N1 |
8.299000E-01 |
|
|
